NCT03091647: Acupressure for Cancer-Related Fatigue

NCT03091647
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: Female
Age: 21 Years to 74 Years (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be able to speak Chinese (Mandarin and/or Cantonese); Patients must have stable disease
Exclusions: Patients who have not completed primary treatments (including surgery, radiation, & chemotherapy) 1-5 years prior to recruitment
https://ClinicalTrials.gov/show/NCT03091647

Comments are closed.

Up ↑